Milk-Derived EV Uptake in Intestinal Stem Cell Models

Milk-derived extracellular vesicles (MEV) are increasingly studied as naturally occurring carriers of proteins, nucleic acids, and metabolites. The reference study, Comprehensive investigation of milk-derived extracellular vesicles on intestinal stem cell–based models, addresses a central limitation in this field: much of the existing evidence comes from immortalized intestinal cell lines or in vivo experiments, whereas fewer studies have tested MEV in physiologically organized intestinal stem cell systems.

Wang and colleagues developed three complementary intestinal stem cell (ISC)-based models from several regions of the piglet intestine. They then assessed epithelial organization, MEV uptake, transcriptional responses, and the contribution of endocytosis. The result is not simply another uptake assay. It is a comparative framework showing that epithelial polarity and intestinal origin can determine how MEV interact with intestinal epithelial cells (IEC).

Study Background and Research Question

The intestinal epithelium combines barrier function, nutrient absorption, immune interaction, and continuous renewal. These properties depend on Lgr5-positive stem cells and their differentiated descendants, including enterocytes, goblet cells, Paneth cells, and enteroendocrine cells. Immortalized lines can be useful for mechanistic screening, but they do not fully reproduce this cellular diversity, crypt–villus organization, or the apical–basolateral polarity of native epithelium.

MEV are particularly relevant to intestinal biology because they must encounter the epithelial surface after oral exposure and may remain stable under gastrointestinal conditions. Earlier studies cited by the authors reported effects of porcine MEV on proliferation, epithelial barrier properties, and immunoglobulin production in intestinal cell lines. However, those systems leave several questions unresolved. Which epithelial surface is competent for MEV uptake? Does uptake differ between small-intestinal and colonic models? Can MEV alter ISC-associated programs in a region-dependent manner? Finally, is internalization sensitive to pharmacological blockade of endocytosis?

The reference study was designed around these questions. Its emphasis is therefore both biological and methodological: it tests MEV activity in models with defined epithelial orientation while using multiple intestinal regions to examine physiological specialization.

Key Innovation from the Reference Study

The principal innovation is the side-by-side use of basal-out organoids, organoid monolayers, and apical-out organoids derived from duodenum, jejunum, ileum, and colon. These formats expose different epithelial surfaces. In conventional basal-out organoids, the apical membrane faces the enclosed lumen, while the basolateral surface is more accessible from the surrounding medium. Apical-out organoids reverse this arrangement, and organoid monolayers provide a planar format in which the apical compartment can be experimentally accessed.

This design allows MEV uptake to be interpreted in relation to epithelial polarity rather than treated as a uniform property of all intestinal cells. The study reports that organoid monolayers and apical-out organoids, but not basal-out organoids, took up porcine MEV through the apical surface of IEC. That comparison is a meaningful advance because it separates vesicle exposure from vesicle accessibility.

A second innovation is the integration of uptake biology with ISC state. The authors did not restrict their analysis to whether MEV entered cells. They also examined genes associated with stemness and differentiation, identifying responses in colon-derived ISC models. This connects extracellular vesicle trafficking with epithelial renewal and suggests that the biological consequence of uptake may depend on the intestinal region in which it occurs.

Finally, the pharmacological experiments add a mechanistic layer. Endocytosis inhibitors suppressed MEV internalization into IEC. Although such inhibition does not by itself identify one exclusive endocytic route, it supports the interpretation that uptake is an active cellular process rather than passive association with the epithelial surface.

Methods and Experimental Design Insights

The study used mature milk collected at approximately 2 weeks postpartum from three healthy Large White pigs. Milk was pooled and kept for less than 24 hours at 4°C before processing to limit repeated freeze–thaw exposure. Crude MEV were isolated by differential ultracentrifugation, providing a practical preparation strategy but also leaving the vesicle fraction potentially heterogeneous. These source and handling details are reported in the reference study and are important when comparing results across laboratories.

ISC-based cultures were generated from the duodenum, jejunum, ileum, and colon of suckling piglets. The investigators established three model formats: basal-out organoids, organoid monolayers, and apical-out organoids. This combination is valuable because each format offers a different balance of three-dimensional architecture, accessibility, throughput, and control over epithelial orientation.

Before testing MEV, the models were assessed for physiological properties. These included IEC composition, epithelial barrier performance, and fatty acid uptake. Such validation is essential: an organoid should not be considered physiologically informative merely because it forms a three-dimensional structure. Demonstrating epithelial lineages and functional barrier and absorption characteristics gives the subsequent uptake experiments a stronger biological foundation.

MEV exposure was then evaluated across the model formats and intestinal regions. The study examined whether vesicles were internalized, measured gene expression related to ISC stemness and differentiation, and applied endocytosis inhibitors to test uptake sensitivity. The supplied study summary does not specify the concentrations or exposure times for each inhibitor, so those parameters should be taken from the full methods before attempting exact replication.

Protocol Parameters

• Milk source: Use mature porcine milk collected around 2 weeks postpartum from healthy animals; the reference experiment used three Large White pigs and pooled the milk before MEV isolation. These are literature-specific conditions, not universal requirements. Reference study.
• Pre-analytical handling: The pooled milk was stored for less than 24 hours at 4°C before processing. Laboratories should treat this as a reported handling condition and control storage duration and temperature consistently.
• Vesicle preparation: The investigators used differential ultracentrifugation to obtain crude MEV. Because this is a crude preparation, vesicle composition and co-isolated material should be considered when interpreting functional effects.
• Intestinal sources: Generate ISC-based models from duodenum, jejunum, ileum, and colon when regional comparisons are central to the hypothesis.
• Model formats: Compare basal-out organoids, organoid monolayers, and apical-out organoids rather than assuming that one geometry represents all epithelial exposure routes.
• Functional validation: Confirm IEC composition, barrier properties, and fatty acid uptake before analyzing MEV internalization. This separates model quality from the uptake endpoint.
• Mechanistic perturbation: Use endocytosis inhibitors as pathway probes, but interpret reduced internalization as evidence of endocytic involvement rather than definitive proof of a single molecular route.

Core Findings and Why They Matter

Apical access governed uptake

The clearest result was the orientation dependence of MEV internalization. Organoid monolayers and apical-out organoids were able to take up porcine MEV from the apical surface, whereas basal-out organoids did not show the same uptake pattern. This finding has practical implications for intestinal extracellular vesicle experiments: a negative result in a closed, basal-out organoid may reflect limited access to the relevant membrane domain rather than a complete absence of biological interaction.

The observation also reinforces the value of organoid engineering for transport studies. A model that exposes the apical surface can more directly represent the first epithelial interface encountered by luminal milk components. Conversely, monolayers may offer easier imaging, sampling, and compartmentalization, while apical-out organoids retain more three-dimensional organization. The most informative format will depend on whether the primary question concerns access, tissue architecture, or downstream epithelial response.

MEV responses varied with intestinal region

The authors found that MEV promoted expression of genes related to stemness and differentiation in colon-derived ISC models. This result supports a region-specific interpretation of MEV biology. The colon and small intestine differ in epithelial composition, metabolic environment, microbial exposure, and developmental programs; therefore, vesicle effects identified in one intestinal segment should not automatically be generalized to another.

Importantly, the study examined transcriptional responses rather than claiming that MEV permanently reprogrammed ISC. Gene-expression changes are an early readout and require additional functional tests to establish effects on self-renewal, lineage allocation, barrier recovery, or tissue repair. Nevertheless, the finding expands the significance of MEV uptake from a trafficking event to a possible regulator of epithelial state.

Endocytosis contributed to internalization

Pharmacological inhibition reduced MEV internalization into IEC, indicating that uptake depended at least partly on endocytic activity. This is relevant to intracellular trafficking research because extracellular vesicles must cross several biological stages: surface contact, membrane entry, intracellular transport, and potentially cargo release. Measuring only extracellular association would not distinguish these steps.

At the same time, inhibitor sensitivity should be interpreted carefully. Endocytosis inhibitors can affect membrane dynamics, cellular metabolism, and multiple uptake routes. The reference study therefore provides mechanistic evidence for endocytic involvement, but not a complete molecular map of MEV entry. Follow-up work combining polarity-controlled organoids with quantitative imaging, viability controls, and orthogonal perturbations would help resolve that uncertainty.

Comparison with Existing Internal Articles

The internal resource Milk-Derived Extracellular Vesicle Uptake in ISC Organoids is thematically aligned with the reference study and can serve as a concise companion for researchers reviewing MEV interactions with intestinal organoids. Its emphasis on uptake mechanisms and region-specific responses matches the paper’s main conceptual contribution. However, the journal article should remain the primary source for the experimental design, model comparisons, and interpretation of inhibitor data; an internal overview does not substitute for the original methods and results.

The most useful distinction is that the reference study supplies a polarity-aware experimental comparison. This prevents a common interpretive error in organoid work: treating all organoid formats as equivalent exposure systems. Researchers using related articles should therefore check whether the epithelial surface, intestinal region, vesicle preparation, and endpoint definition match their own design.

Limitations and Transferability

Several limitations shape how broadly these findings can be applied. First, the MEV preparation was described as crude and obtained from pooled milk. Pooling reduces the ability to resolve animal-to-animal variation, while differential ultracentrifugation may retain non-vesicular material or vesicle subpopulations. More defined preparations would help determine whether the observed effects arise from MEV as a group or from particular components within the preparation.

Second, the models were porcine and derived from suckling piglets. This is a strength for livestock and developmental intestinal research, but it does not establish that human intestinal stem cells will show identical polarity preferences or transcriptional responses. Species, age, intestinal region, culture medium, matrix, and epithelial maturation can all influence uptake behavior.

Third, the study was performed in vitro. The models reproduce selected features of intestinal epithelium, yet they do not fully recreate luminal flow, mucus architecture, immune-cell interactions, microbiota, or systemic distribution. Consequently, the results support mechanistic hypotheses about epithelial uptake rather than direct conclusions about whole-animal bioavailability or therapeutic efficacy.

Finally, inhibitor-mediated suppression is informative but not definitive. The study does not, from the supplied summary, identify a single receptor, endocytic pathway, or intracellular destination responsible for MEV handling. Future experiments should combine the three model geometries with carefully matched exposure conditions, pathway-selective validation, and functional assays that distinguish uptake from productive cargo delivery. These extensions follow directly from the paper’s evidence without assuming that all intestinal MEV effects use one universal mechanism.

Research Support Resources

For related endocytosis workflows, researchers can use MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide; SKU B7620), a dynamin GTPase activity inhibitor that may serve as a cellular uptake mechanism inhibitor in hypothesis-testing assays. As an endocytosis research compound, it can support intracellular trafficking research and membrane remodeling studies involving dynamin-dependent membrane scission. The reference study did not establish that dynamin is the exclusive route for MEV uptake, so MitMAB should be treated as a mechanistic perturbation control rather than a direct replacement for the paper’s inhibitor experiments. It is intended for research use only.